Detalles de la búsqueda
1.
Widely targeted quantitative lipidomics and prognostic model reveal plasma lipid predictors for nasopharyngeal carcinoma.
Lipids Health Dis
; 22(1): 81, 2023 Jun 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37365637
2.
Toripalimab plus capecitabine in the treatment of patients with residual nasopharyngeal carcinoma: a single-arm phase 2 trial.
Nat Commun
; 15(1): 949, 2024 Jan 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38297016
3.
Incidence, consequences, and predictors of serious chemotherapy-induced thrombocytopenia in nasopharyngeal carcinoma.
Cancer Med
; 12(13): 14084-14093, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37212462
4.
Add-on individualizing prediction of nasopharyngeal carcinoma using deep-learning based on MRI: A multicentre, validation study.
iScience
; 25(9): 104841, 2022 Sep 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36034225
5.
Effect of Capecitabine Maintenance Therapy Plus Best Supportive Care vs Best Supportive Care Alone on Progression-Free Survival Among Patients With Newly Diagnosed Metastatic Nasopharyngeal Carcinoma Who Had Received Induction Chemotherapy: A Phase 3 Randomized Clinical Trial.
JAMA Oncol
; 8(4): 553-561, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35175316
Resultados
1 -
5
de 5
1
Próxima >
>>